Cronos Group Inc
TSX:CRON

Watchlist Manager
Cronos Group Inc Logo
Cronos Group Inc
TSX:CRON
Watchlist
Price: 2.86 CAD Market Closed
Market Cap: 1.1B CAD
Have any thoughts about
Cronos Group Inc?
Write Note

Cronos Group Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cronos Group Inc
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Cronos Group Inc
TSX:CRON
Capital Expenditures
-$10.3m
CAGR 3-Years
23%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Canopy Growth Corp
TSX:WEED
Capital Expenditures
-CA$7.1m
CAGR 3-Years
60%
CAGR 5-Years
62%
CAGR 10-Years
4%
Sundial Growers Inc
NASDAQ:SNDL
Capital Expenditures
-CA$7.9m
CAGR 3-Years
-36%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Capital Expenditures
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Knight Therapeutics Inc
TSX:GUD
Capital Expenditures
-CA$32.1m
CAGR 3-Years
48%
CAGR 5-Years
-60%
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
Capital Expenditures
-$89.8m
CAGR 3-Years
-2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Cronos Group Inc
Glance View

Market Cap
1.1B CAD
Industry
Pharmaceuticals

Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The firm is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones, Happy Dance and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones, Happy Dance and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s subsidiaries include Cronos Israel G.S. Cultivation Ltd, Cronos Israel G.S. Manufacturing Ltd., Cronos Israel G.S. Store Ltd. and Cronos Israel G.S. Pharmacy Ltd.

CRON Intrinsic Value
1.61 CAD
Overvaluation 44%
Intrinsic Value
Price

See Also

What is Cronos Group Inc's Capital Expenditures?
Capital Expenditures
-10.3m USD

Based on the financial report for Sep 30, 2024, Cronos Group Inc's Capital Expenditures amounts to -10.3m USD.

What is Cronos Group Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
32%

Over the last year, the Capital Expenditures growth was -330%. The average annual Capital Expenditures growth rates for Cronos Group Inc have been 23% over the past three years , 32% over the past five years .

Back to Top